Reagent

Agricultural Testing Market worth $9.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期二, 六月 6, 2023
Tradition, Legionella, Marketing, Farmer, Fertilizer, Food safety, Biosolids, Pesticide, Soil, Risk, Bureau Veritas, Region, Cereal, ALS, Reagent, Microbial contamination of diesel fuel, Human, Rotation, Water, GMO, Toxicity, Research, USD, ELISA, GM, Polymerase chain reaction, Growth, PCR, Poultry, Seed, GAP, SGS, AsureQuality Limited, Agriculture, Maize, Meat, Food, Water quality, Nutrient, ALS Limited, Genetically modified organism, Microbial inoculant, Salmonella, Speciality chemicals, Vibrio, Solid, Intertek, Clostridium, Seafood, Atmosphere of Earth

The safety testing in application segment accounted for the largest share of the agricultural testing market in 2023 in terms of value.

Key Points: 
  • The safety testing in application segment accounted for the largest share of the agricultural testing market in 2023 in terms of value.
  • Safety testing of agricultural samples includes testing for targets such as toxins, pathogens, heavy metals, pesticides, GMOs, and organic contaminants.
  • The rapid technology of the technology segment accounted for the highest share of the agricultural testing market in 2023 to 2028 in terms of value.
  • The Asia Pacific region accounted for the fastest growing market, in terms of value, of the global agricultural testing market in 2028.

Quantum-Si Bolsters Executive Leadership Team with Four Key Appointments

Retrieved on: 
星期一, 四月 24, 2023
Semiconductor, Health, Technology, Health Technology, Genetics, Pharmaceutical, Biotechnology, Hamamatsu Photonics, Pacific Biosciences, Reagent, Operation, Protein sequencing, Senior, Data science, Marketing, Chief commercial officer, Algorithm, Autocar Sales and Service Building, University of California, Santa Cruz, Oxford Nanoimaging, Research, Genomics, Dicarboxylic acid, Doctor of Philosophy, Proteomics, Protein, UC, Engineering, Epic Sciences, Raytheon Technologies, Drug discovery, Supply, Corisella inscripta, Genetix, Platinum, Management, Fine chemical, Illumina

These appointments follow the commercial launch of Platinum™, the world’s first next-generation, single-molecule protein sequencing platform, and will support Quantum-Si's growing customer base and further scaling of the company.

Key Points: 
  • These appointments follow the commercial launch of Platinum™, the world’s first next-generation, single-molecule protein sequencing platform, and will support Quantum-Si's growing customer base and further scaling of the company.
  • Prior to this, Ms. Atkinson held executive leadership positions at Truvian, Epic Sciences, Edico Genome and Illumina.
  • Mr. Hutcheson has more than 20 years of experience as a commercial professional within the genomics, biotechnology, and drug discovery markets.
  • Its elegant simplicity enables broad-scale access to proteomic data, making it a critical instrument for the future of proteomics research.

Global Glycomics Market Report 2023: Sector to Reach $3.46 Billion by 2028 at a 15.6% CAGR - ResearchAndMarkets.com

Retrieved on: 
星期五, 四月 14, 2023
Health, Biotechnology, Acceleration, Molecular biology, Enzyme, Glycomics, Therapy, Prevalence, Diabetes, Mass spectrometry, COVID-19, Cardiovascular disease, Cancer, DSM-IV codes, Research, Glycobiology, Person, Organization, DART, Acquisition, Investment, Developed country, Application, Medicine, Growth, Drug discovery, Protein engineering, Conditional sentence, R, IonSense, HPLC, Reagent, D, Video game, Pharmaceutical industry, Fine chemical, Medical imaging

The global glycomics market was valued at US$1.46 billion in 2022 and is expected to grow to US$3.46 billion in 2028.

Key Points: 
  • The global glycomics market was valued at US$1.46 billion in 2022 and is expected to grow to US$3.46 billion in 2028.
  • Hence, increased demand for medications and treatments is propelling the pharmaceutical & biotechnology companies sector in the glycomics market forward.
  • China's glycomics market dominated the Asia Pacific market due to the increasing investment, and funding by pharmaceutical companies for glycomics research.
  • The glycomics market is expanding mainly because of increased glycomics research efforts and increased R&D expenditures by pharmaceutical and biotechnology companies.

Global Protein Engineering Market Report 2023: Sector to Reach $7.62 Billion by 2030 at a CAGR of 16.6% - ResearchAndMarkets.com

Retrieved on: 
星期二, 三月 28, 2023
Other Manufacturing, Manufacturing, Eindhoven University of Technology, Therapy, Prevalence, Coronavirus, Biotechnology, COVID-19, Research, Protein engineering, Antibody, USD, Protein, COVID-19 vaccine, Investment, Engineering, Immune system, Conditional sentence, Growth, Insulin, ChromeOS, Tierra, Reagent, Fine chemical, Vaccine, Medical device

The global protein engineering market size is expected to reach USD 7.62 billion by 2030, registering a CAGR of 16.60% during the forecast period.

Key Points: 
  • The global protein engineering market size is expected to reach USD 7.62 billion by 2030, registering a CAGR of 16.60% during the forecast period.
  • The rising number of government activities, such as funding research and advancement for engineering novel therapeutics further influence the industry growth.
  • Furthermore, key companies are expected to have profitable opportunities due to the growth in technological advancements in the protein engineering field.
  • The COVID-19 pandemic has boosted the industry growth due to applications of protein engineering in the production of COVID-19 vaccines and diagnostics.

Global Molecular Diagnostic Market Report to 2030: Technological Advancements in Molecular Diagnostics and Rising Healthcare Expenditure Drives Growth - ResearchAndMarkets.com

Retrieved on: 
星期三, 三月 8, 2023
Health, Other Health, Hepatitis, Polymerase chain reaction, Hospital, PCR, Infection, Diagnosis, DTC, Prevalence, Growth, Houston, Fungal infection, DNA, Lab, Hospital Clinic Manuel Quintela, HIV, POC, Genetic testing, COVID-19, Reagent, Conditional sentence, Vaccine, Health care, Sequencing, Software

After extensive primary and secondary research, the report provides an in-depth analysis of the molecular diagnostics market.

Key Points: 
  • After extensive primary and secondary research, the report provides an in-depth analysis of the molecular diagnostics market.
  • The report also provides insights into the key drivers, restraints, challenges, and opportunities in the molecular diagnostics market.
  • The growth of this market is driven by the rising global geriatric population, the increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures.
  • The large market share of this segment is attributed to technological advancements and increased usage of diagnostic kits in healthcare settings.

Global DNA-RNA Sample Preparation Market Report 2022: Emergence of Scientific Investigation in the Form of RNA Interference (RNAi) Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
星期一, 一月 23, 2023
Biotechnology, Genetics, Health, Investment, Midsayap Diagnostic Center and Hospital, Ansoff matrix, COVID-19, Market development, Geography, Porter's five forces analysis, Reagent, SWOT, Risk, Workstation, USD, Contract research organization, Growth, Observation, Hospital, Vaccine, Medical device, Retail, Application

The Global DNA-RNA Sample Preparation Market is segmented based on Type, Application, End User, and Geography.

Key Points: 
  • The Global DNA-RNA Sample Preparation Market is segmented based on Type, Application, End User, and Geography.
  • By End User, the market is classified into Academic & Research Institute, Contract Research Organization, Diagnostic Centers, Forensic Labs, and Hospitals.
  • The report presents a detailed Ansoff matrix analysis for the Global DNA-RNA Sample Preparation Market.
  • The report offers a comprehensive evaluation of the Global DNA-RNA Sample Preparation Market.

Global DNA-RNA Sample Preparation Market Report 2022: Growing Research in Molecular Biology Analysis Bolsters Sector

Retrieved on: 
星期二, 一月 24, 2023
Reagent, USD, COVID-19, Workstation, Contract research organization, Market development, Ansoff matrix, Midsayap Diagnostic Center and Hospital, Observation, Porter's five forces analysis, Growth, SWOT, Geography, Hospital, Risk, Investment, Vaccine, Medical device, Retail, Application

The Global DNA-RNA Sample Preparation Market is segmented based on Type, Application, End User, and Geography.

Key Points: 
  • The Global DNA-RNA Sample Preparation Market is segmented based on Type, Application, End User, and Geography.
  • By End User, the market is classified into Academic & Research Institute, Contract Research Organization, Diagnostic Centers, Forensic Labs, and Hospitals.
  • The report presents a detailed Ansoff matrix analysis for the Global DNA-RNA Sample Preparation Market.
  • The report offers a comprehensive evaluation of the Global DNA-RNA Sample Preparation Market.

Preclinical Imaging Global Market Report 2023: Sector to Reach $3.93 Billion by 2030 at a 6.51% CAGR

Retrieved on: 
星期一, 一月 23, 2023
Photon, Reagent, Modality, Drug discovery, Research, Private, Single-photon emission computed tomography, Strategic management, Market share analysis, Use, Magnetic resonance imaging, Positron emission tomography, Pathfinder, Institute for Governance of Private and Public Organizations, Magnetic particle imaging, COVID-19, Application, MRI, Business Growth Fund, User (computing), Value, Optical flow, Customer support, Medical imaging, Pharmaceutical industry, Retail

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Preclinical Imaging Market.

Key Points: 
  • The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Preclinical Imaging Market.
  • The Global Preclinical Imaging Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.
  • What is the market share of the leading vendors in the Global Preclinical Imaging Market?
  • What modes and strategic moves are considered suitable for entering the Global Preclinical Imaging Market?

BenchSci Announces Launch of ASCEND™ – a First-of-its-Kind ‘Map’ of All Disease Biology that Aims to Transform Pharmaceutical Research

Retrieved on: 
星期二, 一月 31, 2023
Disease, Pharmacy, Publication, Entrepreneurship, Golden Venture, Software as a service, Patient, Drug discovery, Hope, Medicine, Reagent, Biology, TCV, ASCEND, Pharmaceutical industry, Fine chemical, Research, Amgen

ASCEND harnesses BenchSci's proprietary machine learning technology that is trained by scientists to extract experimental evidence from internal and external sources.

Key Points: 
  • ASCEND harnesses BenchSci's proprietary machine learning technology that is trained by scientists to extract experimental evidence from internal and external sources.
  • Using curated ontology datasets, it makes connections across experiment outcomes to create the first commercially available, unbiased and evidenced-based map of the underlying biology of disease.
  • “With ASCEND, BenchSci has developed a unique approach to extracting and connecting scientific evidence from within and outside Amgen.
  • Based on results across many programs, we are excited to continue to provide ASCEND by BenchSci broadly across the organization to catalyze our research.

Nautilus Biotechnology Expands to San Diego

Retrieved on: 
星期四, 一月 26, 2023
Health, Biotechnology, Nautilus, Proteome, Translational Genomics Research Institute, University Town Center, Proteomics, San Francisco Bay Area, Amgen, MD Anderson Cancer Center, SVP, Genentech, Reagent, Research, Engineering, Fine chemical

SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the opening of its new office space at University Town Center in San Diego, California.

Key Points: 
  • SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the opening of its new office space at University Town Center in San Diego, California.
  • The initial 7,000-square-foot space will house Nautilus’ San Diego workforce including mechanical engineering, reagent development, software engineering, and bioinformatics, with the ability to expand further as it grows.
  • The expansion of Nautilus’ footprint into one of the largest biotechnology and pharmaceutical hubs in the country capitalizes on the company’s growing scientific and business momentum.
  • He is joined by fellow longtime San Diego biotechnology executive Ken Kuhn, Ph.D., Vice President of Reagent and Platform Development at Nautilus, who will help build out the company’s team in the region as well as at its research and development headquarters in San Carlos, California.